USPTO serial 79259402
ABTEI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 24, 2020
- Examiner
- PARKS, KIMBERLY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ABTEI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Omega Pharma Innovation & Development NV
BE
Other trademarks owned by Omega Pharma Innovation & Development NV
Omega Pharma Innovation & Development NV
BE
Other trademarks owned by Omega Pharma Innovation & Development NV
Omega Pharma Innovation & Development NV
BE
Other trademarks owned by Omega Pharma Innovation & Development NV
Omega Pharma Innovation & Development NV
BE
Other trademarks owned by Omega Pharma Innovation & Development NV
Perrigo Pharma International DAC
IE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anessa Owen Kramer
Anessa Owen Kramer Honigman LLP39400 Woodward Avenue, Suite 101Bloomfield Hills, MI 48304UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medicinal preparations and substances for human use for the treatment of nasal congestion, colds and allergy symptoms; vitamins, minerals and food supplements for medical use; food supplements, namely, valerian tablets and capsules, garlic pills and capsules; herbs and herbal extracts for medicinal purposes; beverages for medical purposes, namely herbal teas for medical purposes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Omega Pharma Innovation & Development NV
- Other trademarks owned by Omega Pharma Innovation & Development NV
- Other trademarks owned by Omega Pharma Innovation & Development NV
- Other trademarks owned by Omega Pharma Innovation & Development NV
- Other trademarks owned by Perrigo Pharma International DAC
- Other trademarks in Class 005
- Similar marks named ABTEI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 13, 2026 | C71T | CANCELLED SECTION 71 | — |
| Aug 6, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 24, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 20, 2025 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jan 3, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 19, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 19, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 6, 2023 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Sep 26, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 3, 2020 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Aug 3, 2020 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jun 24, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 24, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 7, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 7, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 3, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 18, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 18, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 18, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 3, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 2, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 2, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 2, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 26, 2019 | GAUN | NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED | — |
| Aug 26, 2019 | GAUD | NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED | — |
| Aug 26, 2019 | NAUD | REPORT UNRESPONSIVE AMENDMENT - COMPLETED | — |
| Aug 13, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 13, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 9, 2019 | ALIE | ASSIGNED TO LIE | — |
| Aug 9, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 2, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 1, 2019 | GAUN | NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED | — |
| Aug 1, 2019 | GAUD | NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED | — |
| Aug 1, 2019 | NAUD | REPORT UNRESPONSIVE AMENDMENT - COMPLETED | — |
| Jul 30, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 30, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 30, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 23, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 23, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 18, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 2, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 1, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 24, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 14, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 4, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 29, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 25, 2019 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| May 23, 2019 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |